According to our data, CO in conjunction with other MetS risk factors did not modulate necessarily the same signalling peptides (i.e., AG, UnAG, obestatin, GH and obestatin/ghrelin ratio) in the ghrelin signalling and GH/IGF-1 axis. This evidence concerns the gene IGF1 and metabolic syndrome.